Processa Pharmaceuticals develops products that improve survival and quality of life for patients with unmet medical needs. Using our years of regulatory experience, we identify de-risked, underappreciated drugs and develop assets with an unmet medical need and leverage prior research toward high value clinical milestones and a lower risk of development failure. Our portfolio of candidates is disease agnostic and all programs must meet strict evaluation criteria for further development including (but not limited to): representing an unmet medical need; have demonstrated (preferably in humans) clinical evidence of efficacy; that our Regulatory Science approach can make a difference in the time, cost and risk to obtaining marketing authorization and thus are highly capital efficient and contributes to substantial returns on equity.